Dissolved and financials
CVR: 38280309
DKK -4,000
Gross profit
Net result: DKK -32,538
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 3 June 2021
CVR · view overview
0 employees
Annual report 2018 · average
Director role ended: Jens Ellebjerg Hansen
CVR · 17/12/2020
View the full event history
ADoN Biomarkers IVS was a Danish company of the type Iværksætterselskab based in Farum, founded in 2016. The company has been dissolved on 3 June 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. According to the 2018 annual report, the company had an average of 0 employees. In 2018, the company reported a gross profit of DKK -4,000 and a net result of DKK -32,538 compared with DKK -5,000 the year before. Equity in the 2018 report amounted to DKK -37,536.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/01/2018 – 31/12/2018 | -4 t. | -33 t. | 1 t. | -38 t. | 0 | |
| 201722/12/2016 – 31/12/2017 | -5 t. | -5 t. | 2 | -5 t. | 0 |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. ADoN Biomarkers IVS is registered in the Danish CVR register with the status Dissolved and ceased on 3 June 2021.
The CVR number of ADoN Biomarkers IVS is 38280309.
In 2018, ADoN Biomarkers IVS reported a gross profit of DKK -4,000.
ADoN Biomarkers IVS had an average of 0 employees in the 2018 financial year according to the annual report.
ADoN Biomarkers IVS was founded on 22 December 2016.
ADoN Biomarkers IVS was registered under the industry Konsulentbistand vedrørende informationsteknologi (industry code 620200).
ADoN Biomarkers IVS was dissolved on June 3, 2021.
As of December 17, 2020, Jens Ellebjerg Hansen has stepped down as liquidator of ADoN Biomarkers IVS.
On December 17, 2020, ADoN Biomarkers IVS exited liquidation.
As of December 7, 2020, Jens Ellebjerg Hansen is registered as liquidator of ADoN Biomarkers IVS.
On December 7, 2020, ADoN Biomarkers IVS entered liquidation.
As of October 22, 2020, Poul Jørgen Jennum has stepped down as director of ADoN Biomarkers IVS.
As of October 22, 2020, Helge Bjarup Dissing Sørensen has stepped down as director of ADoN Biomarkers IVS.
ADoN Biomarkers IVS has published its annual report for 2018. Gross profit came to DKK -4,000, and the net result was DKK -32,538.
ADoN Biomarkers IVS has published its annual report for 2017. Gross profit came to DKK -5,000, and the net result was DKK -5,000.
As of December 22, 2016, Poul Jørgen Jennum is registered as director of ADoN Biomarkers IVS.
As of December 22, 2016, Helge Bjarup Dissing Sørensen is registered as director of ADoN Biomarkers IVS.
ADoN Biomarkers IVS was founded on December 22, 2016.
